葛根素调控蛋白激酶B/糖原合成酶激酶-3β通路抑制糖尿病心肌病大鼠的心肌细胞铁死亡

Puerarin regulates protein kinase B/glycogen synthase kinase-3β pathway to inhibit ferroptosis of cardiomyocytes in rats with diabetic cardiomyopathy

  • 摘要:
    目的  探讨葛根素(Pue)对糖尿病心肌病(DCM)大鼠心肌细胞铁死亡的影响,并分析其可能的作用机制。
    方法  采取高脂高糖饮食+链脲佐菌素注射构建DCM大鼠模型。将造模成功的大鼠设为DCM组、Pue低剂量组(125 mg/kg, 灌胃)、Pue高剂量组(250 mg/kg, 灌胃)和缬沙坦组(30 mg/kg, 灌胃),每组10只。另选10只健康SD大鼠设为空白组。治疗结束时,检测各组大鼠空腹血糖、尾动脉血压(BP)、总胆固醇(TC)、甘油三酯(TG)和低密度脂蛋白胆固醇(LDL-C)水平。采用超声仪记录各组大鼠心功能相关指标左心室射血分数(LVEF)、左室短轴缩短率(LVFS)、左室收缩期末内径(LVDs)和左室舒张期末内径(LVDd)。采用苏木精-伊红(HE)染色、TUNEL染色观察各组心肌病理组织学变化。采用酶联免疫吸附试验(ELISA)试剂盒检测各组大鼠谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)、活性氧(ROS)、丙二醛(MDA)和Fe2+水平。采用蛋白免疫印迹检测谷胱甘肽过氧化物酶4(GPX4)、长链脂酰辅酶A合成酶4(ACSL4)和蛋白激酶B/糖原合成酶激酶-3β(AKT/GSK-3β)通路相关蛋白表达。
    结果  与空白组比较, DCM组大鼠心肌纤维紊乱或断裂,有大量炎性细胞浸润。DCM组的细胞凋亡率、LVDs、LVDd、血糖、BP、TC、TG、LDL-C、ROS、MDA、Fe2+和ACSL4蛋白表达水平高于空白组, LVEF、LVFS、GSH-Px、SOD和GPX4、磷酸化(p)-AKT、p-GSK-3β、p-PI3K蛋白表达水平低于空白组,差异有统计学意义(P<0.05)。与DCM组比较, Pue低剂量组、Pue高剂量组和缬沙坦组大鼠的心肌纤维断裂或紊乱减轻,心肌纤维排列较为整齐,炎性细胞浸润减少。Pue低剂量组、Pue高剂量组和缬沙坦组的细胞凋亡率、LVDs、LVDd、血糖、BP、TC、TG、LDL-C、ROS、MDA、Fe2+和ACSL4蛋白表达水平低于DCM组, LVEF、LVFS、GSH-Px、SOD和GPX4、p-AKT、p-GSK-3β、p-PI3K蛋白表达水平高于DCM组,差异有统计学意义(P<0.05), 且Pue高剂量组作用效果更显著。
    结论  Pue治疗能够有效改善DCM大鼠代谢水平,抑制心肌细胞病理损伤和凋亡,减轻氧化应激,进而改善DCM大鼠的心功能,其作用机制可能与抑制AKT/GSK-3β通路介导的心肌细胞铁死亡有关。

     

    Abstract:
    Objective  To investigate the effect of puerarin(Pue)on ferroptosis in myocardial cells of rats with diabetic cardiomyopathy (DCM) and to analyze its potential mechanisms.
    Methods  A DCM rat model was established by high-fat, high-sugar diet combined with streptozotocin injection. The successfully modeled rats were randomly divided into DCM group, low-dose Pue group (125 mg/kg, gavage), high-dose Pue group (250 mg/kg, gavage) and valsartan group (30 mg/kg, gavage), with 10 rats in each group. Another 10 healthy SD rats were selected as blank control group. At the end of treatment, fasting blood glucose, tail artery blood pressure (BP) total cholesterol (TC), triglycerides (TG) and low-density lipoprotein cholesterol (LDL-C) levels were measured in all groups. The cardiac function related indicatorsleft ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), left ventricular end-systolic diameter (LVDs) and left ventricular end-diastolic diameter (LVDd) of rats in each group were recorded by ultrasonic apparatus. Histopathological changes in myocardial tissues were observed using hematoxylin-eosin (HE) staining and TUNEL staining. Levels of glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), reactive oxygen species (ROS), malondialdehyde (MDA) and Fe2+were detected using enzyme-linked immunosorbent assay (ELISA) kits. Western blotting was used to detect the expression levels of glutathione peroxidase 4 (GPX4), long-chain acyl-CoA synthetase 4 (ACSL4) and proteins involved in the protein kinase B/glycogen synthase kinase-3β (AKT/GSK-3β) signaling pathway.
    Results  Compared with the blank control group, the DCM group exhibited disordered or fractured myocardial fibers and significant inflammatory cell infiltration. The apoptosis rate, LVDs, LVDd, blood glucose, BP, TC, TG, LDL-C, ROS, MDA, Fe2+ and ACSL4 protein expression levels in the DCM group were significantly higher, and LVEF, LVFS, GSH-Px as well as SOD and the protein expression levels of GPX4, phosphorylated (p) -AKT, p-GSK-3β and p-PI3K were lower than those in the blank group (P < 0.05). Compared with the DCM group, the low-dose Pue group, high-dose Pue group and valsartan group showed reduced fractured myocardial fiber or disarray, more regular arrangement of myocardial fibers, and decreased inflammatory cell infiltration. The apoptosis rate, LVDs, LVDd, blood glucose, BP, TC, TG, LDL-C, ROS, MDA, Fe2+ and ACSL4 protein expression levels in the low-dose Pue group, high-dose Pue group and valsartan group were significantly lower, and LVEF, LVFS, GSH-Px as well as SOD and the protein expression levels of GPX4, p-Akt, p-GSK-3β and p-PI3K were significantly higher than those in the DCM group (P < 0.05), and the effect was more significant in the high-dose Pue group.
    Conclusion  Pue treatment can effectively improve the metabolic level of DCM rats, inhibit the pathological damage and apoptosis of cardiomyocytes, alleviate oxidative stress, and thereby improving the cardiac function of DCM rats. Its mechanism of action may be related to the inhibition of cardiomyocyte ferroptosis mediated by the AKT/GSK-3β pathway.

     

/

返回文章
返回